Con Hennessy Interview with Rare Revolution Magazine
We are delighted to announce that our CEO, Con Hennessy, has been featured in esteemed rare disease publication Rare Revolution, in their “The People of Rare: CEO Series” campaign.The Rare Revolution “People of Rare” campaign aims to provide a glimpse into what drives the leaders of various RARE communities and some of the industry’s most influential organisations. In Con’s interview, he opens up on a variety of topics such as his path to working in the rare disease space, the challenging and rewarding aspects of his position and what motivates him to continue to make a difference.
The interview is available on the Rare Revolution Magazine website: https://www.rarerevolutionmagazine.com/ceo-series/con-hennessy-of-openapp
“We firmly believe in the merit of registries as a means for organisations dealing with rare disease to bolster community engagement with researchers, advance support of treatments, assess drug efficacy/safety and longitudinal data collection.” - Con Hennessy
Geospatial Needs Analysis = Right Service In The Right Place Historically, new mental health staff were hired on a national basis and assigned to their nearby Community Healthcare Organization (or CHOs). While additional resources were welcome, this approach ignored community need in regards to the right services provided by the…Read More
OpenApp Celebrates 20th Anniversary OpenApp is delighted to announce: we’ve turned 20! From starting with a focus on open source software in Ireland and the EU, to the global expansion into patient registries to support patient advocacy, disease research, and treatment efficacy research, we’ve greatly expanded our impact on healthcare…Read More
Increasing Patient Communication and Engagement: How Children’s Tumour Foundation (CTF) are reaching more patients Through Multi-Language Functionality
Increasing Patient Communication and Engagement: How Children’s Tumour Foundation (CTF) are reaching more patients Through Multi-Language Functionality OpenApp are pleased to announce the NF Registry by Children’s Tumour Foundation (CTF) is now live in four additional languages: French, Italian, Portuguese and Spanish. This new enhancement provides access to the registry…Read More